Vol. 45 No. 4 (2023): Experimental Oncology

View Vol. 45 No. 4 (2023): Experimental Oncology
DOI: https://doi.org/10.15407/exp-oncology.2023.04
Published: 03.02.2024

Reviews

  • GENETIC PREDICTORS OF TOXIC EFFECTS OF METHOTREXATE IN CANCER PATIENTS

    L. Fishchuk, O. Skavinska, O. Ievseienkova, Z. Rossokha, L. Sheiko
    399-408
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.399

Original contributions

  • SYSTEMIC INFLAMMATORY INDICES IN PATIENTS WITH MALIGNANT GLIOMAS AND EFFECTS OF PLATELET SECRETOME IN VITRO

    V. Rozumenko, L. Liubich, E. Pedachenko, L. Staino, D. Egorova, L. Kot, T. Malysheva
    409-420
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.409

  • EXPRESSION PROFILE OF miR-145, -182, -21, -27a, -29b, and -34a IN BREAST CANCER PATIENTS OF YOUNG AGE

    V. Chekhun, T. Borikun, O. Mushii, T. Zadvornyi, О. Martyniuk, E. Kashuba, V. Bazas, S. Hrybach, M. Krotevych, S. Lyalkin, N. Lukianova
    421-431
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.421

  • TUMOR MICROENVIRONMENT-ASSOCIATED miR-7-5p, miR-19a-3p, AND miR-23b-3p EXPRESSION IN PROSTATE CANCER WITH DIFFERENT PROGRESSION RISK

    T. Borikun, O. Mushii, A. Pavlova, T. Burda, T. Zadvornyi
    432-442
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.432

  • PROGNOSTIC SIGNIFICANCE OF microRNA-100, -125b, AND -200b IN PATIENTS WITH COLORECTAL CANCER

    S. Maliborska, V. Holotiuk, Y. Partykevych, O. Rossylna
    443-450
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.443

  • ASSESSMENT OF CIRCULATING miRNA LEVELS IN BREAST CANCER PATIENTS DEPENDING ON CLINICAL CHARACTERISTICS AND CHEMOTHERAPY

    О. Harashchenko
    451-456
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.451

  • SOLUBLE CD150 ISOFORM LEVEL IN PLASMA OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

    I. Gordiienko, V. Scherbina, L. Shlapatska
    457-462
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.457

  • СANCER INCIDENCE IN UKRAINE: TRENDS IN 2010-2019 AND THE IMPACT OF COVID-19 PANDEMIC

    Yu.I. Michailovich, O.V. Sumkina, Ye.L. Gorokh
    463-473
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.463

  • NOT OTHERWISE SPECIFIED T-CELL LYMPHOMA: OUTCOMES OF A SINGLE CENTER STUDY

    I. Kriachok, I. Tytorenko, N. Shudrak, O. Aleksik, Ya. Stepanishyna, T. Kadnikova, Ya. Pastushenko, N. Shokun , T. Rudiyk, M. Bushuieva
    474-482
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.474

  • CORONAVIRUS SARS-COV-2 MODIFIES ANTITUMOR REDOX STATUS OF BLOOD AND INTERCELLULAR MATRIX IN METASTATIC COLORECTAL CANCER PATIENTS (A PILOT STUDY)

    A.P. Burlaka, D.L. Liubenko, A.A. Burlaka, O.I. Yevtushenko, I.I. Ganusevich
    483-492
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.483

  • INFRARED THERMAL IMAGING CONTROL OF RADIATION DERMATITIS DYNAMICS

    L. Miroshnichenko, L. Vasiliev, G. Shustakova, E. Gordiyenko, Yu. Fomenko, I. Dunaieva
    493-503
    DOI: https://doi.org/10.15407/exp-oncology.2023.04.493

Methods and techniques

Case report

Conference report

Obituary